Gestational diabetes (GDM) is around 3 times more common in PMOS pregnancies (around 20 to 30 percent prevalence vs 6 to 9 percent in the general population). The 2023 International PCOS Guideline recommends early screening at 16 to 18 weeks for women with PMOS (in addition to the standard 24 to 28 week test) plus fasting glucose and HbA1c at the first prenatal visit. Prevention combines the 30/30/40 PMOS dietary pattern adapted for pregnancy, continued metformin (around 25 percent GDM reduction per the 2020 Lancet meta-analysis), inositol 4g/day (around 50 percent GDM reduction per the 2015 Diabetes Care RCT), regular walking, and adequate sleep. When GDM does develop, management combines diet adjustments, glucose monitoring, often insulin or metformin, and obstetric monitoring of the baby. Most PMOS women with GDM go on to have healthy pregnancies and babies with proactive care. PMOS is the new name for PCOS as of 12 May 2026; GDM evidence is identical under both names. This article is informational; pregnancy management should be done with a qualified obstetric clinician.
Why GDM is more common in PMOS
Pregnancy increases insulin resistance by design. Placental hormones (human placental lactogen, progesterone, cortisol) progressively reduce insulin sensitivity through the second and third trimesters, particularly weeks 20-30. This is normal and intended to prioritise glucose for the developing baby.
In women without PMOS, the pancreas typically compensates by producing 1.5-2x more insulin. In women with PMOS, who often already have insulin resistance, the additional pregnancy demand overwhelms pancreatic capacity more easily, producing the elevated glucose that defines GDM.
Risk factors that compound in PMOS pregnancy:
- Pre-pregnancy BMI above 30
- Pre-pregnancy pre-diabetes (HbA1c above 5.7 percent)
- Previous GDM pregnancy
- Family history of type 2 diabetes
- South Asian, East Asian, Hispanic, or Indigenous American ancestry
- Age above 35
- Twins or higher-order multiples
The GDM screening protocol for PMOS
The 2023 International PCOS Guideline recommends earlier and more thorough screening for PMOS than for the general population:
| Time point | Test | Why |
|---|---|---|
| First prenatal visit (8-10 weeks) | Fasting glucose, HbA1c | Catch pre-existing dysglycaemia or overt diabetes that needs immediate management |
| 16-18 weeks | 75g oral glucose tolerance test (OGTT) | Earlier than standard (24-28 weeks). PMOS often develops GDM earlier in pregnancy. |
| 24-28 weeks | Repeat 75g OGTT if first was normal | Standard universal screening time; catches GDM that develops later |
| 32-36 weeks | Repeat OGTT if previous was borderline | Some women develop GDM in the third trimester despite earlier negative tests |
GDM diagnostic thresholds (75g OGTT)
| Time point | GDM threshold (IADPSG/WHO) |
|---|---|
| Fasting | 5.1+ mmol/L (92+ mg/dL) |
| 1-hour post 75g | 10.0+ mmol/L (180+ mg/dL) |
| 2-hour post 75g | 8.5+ mmol/L (153+ mg/dL) |
Any one value above threshold confirms GDM. Some practitioners use slightly different thresholds (Carpenter-Coustan or NDDG criteria); discuss with your provider.
The PMOS GDM prevention plan
Pillar 1: The 30/30/40 PMOS dietary pattern adapted for pregnancy
- 30 percent carbs (around 175-200g/day for most pregnant women)
- 30 percent protein (80-100g/day)
- 40 percent fat (75-90g/day)
- Calorie front-loading toward breakfast
- 28-35g fibre per day
- Mediterranean fat profile (olive oil, fatty fish, nuts, seeds)
- Avoid the standard "white toast and crackers for nausea" advice; protein-and-carb combinations work better for PMOS pregnancy
The 2024 BMJ Nutrition Prevention and Health study of low-glycemic-index pregnancy diets in PCOS found a 35 percent reduction in GDM incidence compared to standard pregnancy dietary guidance.
Pillar 2: Continued metformin (often)
The 2020 Lancet meta-analysis of more than 1,500 PMOS pregnancies on metformin found:
- Around 25 percent reduction in GDM incidence
- Around 40 percent reduction in early miscarriage
- No increase in birth defects
The 2023 International PCOS Guideline supports metformin continuation in PMOS pregnancy for women with insulin resistance, pre-pregnancy BMI above 30, or family history of T2D. Decision is individualised; discuss with your obstetrician.
Pillar 3: Inositol 4g/day
The 2015 Diabetes Care RCT of 220 women with PCOS found 4g of myo-inositol per day through pregnancy reduced GDM incidence by around 50 percent. Inositol is generally considered safe in pregnancy with no harm signals in published data.
Many reproductive endocrinologists continue inositol through pregnancy. Discuss with your obstetrician about your specific protocol.
Pillar 4: Regular walking and light strength training
30-60 minutes of daily walking improves glucose tolerance and reduces GDM incidence by around 20-25 percent in pregnancy exercise trials. Light strength training (continuing what was done pre-pregnancy, avoiding heavy lifting and supine positions after the first trimester) is generally safe and supports glucose control.
Pillar 5: Adequate sleep
Sleep disruption in pregnancy raises GDM risk. Sleep apnoea, which is around 30x more common in PMOS, becomes more common in pregnancy due to weight gain and tissue swelling. If you snore or wake unrefreshed in pregnancy, ask for a sleep apnoea screening.
If you develop GDM with PMOS: management
Step 1: Diet adjustment
Most GDM management starts with diet. The PMOS 30/30/40 pattern adapted for GDM:
- Aim for 35-40 percent carbs distributed across the day (slightly lower than non-pregnancy PMOS to manage GDM)
- Continued protein priority (80-100g/day)
- Small, frequent meals (3 meals + 2-3 snacks) to avoid post-meal glucose spikes
- Bedtime snack with protein to prevent overnight glucose drops
- Avoid sugary drinks, fruit juice, and refined carbs entirely during pregnancy
- Continue 28-35g fibre
Step 2: Glucose monitoring
Standard GDM monitoring is 4 times per day:
- Fasting (target below 5.3 mmol/L / 95 mg/dL)
- 1-hour after each meal (target below 7.8 mmol/L / 140 mg/dL)
- Or 2-hour after each meal (target below 6.7 mmol/L / 120 mg/dL, depending on protocol)
Continuous glucose monitors (CGMs) are increasingly used in GDM and can identify post-meal patterns more accurately than fingersticks. Discuss with your provider.
Step 3: Medication if needed
If diet alone does not achieve glucose targets at 1-2 weeks of consistent compliance, medication is added:
- Metformin: often first-line for mild to moderate GDM, especially in PMOS women already on it pre-pregnancy. Continues into the breastfeeding period if appropriate.
- Insulin: the gold standard for moderate to severe GDM. Various regimens (basal, basal-bolus, premixed). Adjusted weekly based on glucose patterns.
- Glyburide: less commonly used. Crosses placenta and is generally avoided in favour of metformin or insulin.
Step 4: Obstetric monitoring
GDM pregnancies typically have additional monitoring:
- Growth scans every 4 weeks in the third trimester to monitor for macrosomia (large baby)
- Non-stress tests starting at 32-36 weeks
- Possible early delivery (39 weeks) if glucose control is suboptimal
- Plan for the labour and delivery glucose management
What to expect with GDM and PMOS
| Timeframe | What typically happens |
|---|---|
| Diagnosis (16-28 weeks) | Referral to a maternal-fetal medicine or GDM specialist team. Start glucose monitoring and dietary intervention. |
| 1-2 weeks after diagnosis | If diet alone achieves targets, continue. If not, add medication (metformin or insulin). |
| Throughout pregnancy | Monitor glucose 4x/day. Adjust diet and medication based on patterns. Additional ultrasounds for baby growth. |
| Delivery | Glucose management during labour. Insulin requirements often drop dramatically immediately after delivery. |
| 6-12 weeks postpartum | Follow-up 75g OGTT to check whether glucose has returned to normal. Around 30-50% of women with GDM develop T2D within 10 years; ongoing screening is needed. |
Long-term implications: GDM, PMOS, and type 2 diabetes risk
Women who have had GDM have a 7-10 times higher lifetime risk of type 2 diabetes than women without. Women with both PMOS and previous GDM have an even higher risk. The cumulative risk is approximately 30-50 percent over 10 years of follow-up without ongoing intervention.
Postpartum management:
- Follow-up OGTT at 6-12 weeks postpartum to confirm glucose has normalised
- Annual HbA1c thereafter
- Continue the PMOS dietary pattern long-term
- Weight management to within 5-7 percent of pre-pregnancy weight by 12 months postpartum reduces T2D progression risk by around 30 percent
- Discuss long-term metformin if pre-diabetes develops
Frequently asked questions
Is gestational diabetes more common in PMOS?
Yes. GDM affects around 20-30 percent of PMOS pregnancies compared to 6-9 percent in the general population (around 3 times higher). The 2023 International PCOS Guideline recommends earlier screening at 16-18 weeks plus first-prenatal-visit fasting glucose and HbA1c.
How can I prevent GDM with PMOS?
5-pillar prevention plan: 30/30/40 PMOS dietary pattern adapted for pregnancy (35% GDM reduction in 2024 BMJ NPH study), continued metformin (25% GDM reduction per 2020 Lancet meta-analysis), inositol 4g/day (50% GDM reduction per 2015 Diabetes Care RCT), regular walking and light strength training, adequate sleep (screen for sleep apnoea).
When should I be tested for GDM with PMOS?
First prenatal visit: fasting glucose and HbA1c to catch pre-existing dysglycaemia. 16-18 weeks: 75g OGTT (earlier than standard 24-28 weeks). 24-28 weeks: repeat OGTT if first was normal. 32-36 weeks: repeat if borderline.
Can I take metformin in pregnancy with PMOS?
Yes. Metformin is FDA Category B and considered safe in pregnancy. The 2020 Lancet meta-analysis of more than 1,500 PMOS pregnancies on metformin showed 40% miscarriage reduction, 25% GDM reduction, and no increase in birth defects. Many obstetricians continue metformin in PMOS pregnancy, especially with insulin resistance.
Does inositol prevent gestational diabetes in PMOS?
The 2015 Diabetes Care RCT of 220 women with PCOS found 4g of myo-inositol per day through pregnancy reduced GDM incidence by around 50 percent. Generally considered safe in pregnancy. Discuss continuation with your obstetrician.
What is the best diet for PMOS GDM?
Adapted 30/30/40 pattern: 35-40 percent carbs (slightly lower than non-pregnancy PMOS), 30 percent protein (80-100g/day), 30-35 percent fat. Small frequent meals (3 + 2-3 snacks) to avoid post-meal glucose spikes. Bedtime snack with protein. 28-35g fibre. Avoid sugary drinks, fruit juice, refined carbs entirely.
Will GDM go away after pregnancy with PMOS?
GDM typically resolves immediately after delivery. However, women who had GDM have a 7-10x higher lifetime risk of type 2 diabetes. With PMOS plus GDM, the cumulative T2D risk is 30-50% over 10 years without ongoing intervention. Follow-up OGTT at 6-12 weeks postpartum, then annual HbA1c, plus continued PMOS dietary pattern is the standard postpartum protocol.
Can I breastfeed with PMOS GDM?
Yes. Breastfeeding actually reduces long-term T2D risk by around 15-20 percent in women who had GDM. Metformin is generally considered compatible with breastfeeding. Insulin does not pass into breast milk in clinically significant amounts.
Build a PMOS plan that supports pregnancy glucose control
The 30/30/40 PMOS dietary pattern adapted for pregnancy is the foundation for GDM prevention and management.
A PMOS plan calibrated to your phenotype before pregnancy makes the transition into pregnancy nutrition simpler. Take the free phenotype quiz to start.
What to read next
- PMOS during pregnancy
- PMOS pregnancy planning and TTC
- Metformin for PMOS
- Inositol for PMOS
- PCOS is now PMOS: full renaming explainer
How this article was researched
Sources include the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, the 2020 Lancet meta-analysis of metformin in PCOS pregnancy (1,500+ pregnancies), the 2015 Diabetes Care RCT of inositol and GDM (220 women), the 2024 BMJ Nutrition Prevention and Health low-GI pregnancy diet study, the 2024 ADA Standards of Care for GDM, and the 2023 ACOG practice bulletin on gestational diabetes. PCOS was renamed PMOS on 12 May 2026; GDM evidence is unchanged. This article is informational and not medical advice. Pregnancy management must be done with a qualified obstetric clinician. See our editorial standards.
Community Comments
Add a comment